PIPR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Piper Sandler Companies (PIPR) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. Despite mixed technical indicators, the company's strong recent financial performance, positive analyst upgrades, and growing M&A pipeline make it a compelling long-term investment opportunity.
The technical indicators are mixed. The MACD is below zero and negatively contracting, suggesting bearish momentum. The RSI is neutral at 36.413, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below the pivot level of 308.048, with key support at 291.103 and resistance at 324.994. These signals indicate a cautious short-term outlook but do not negate long-term potential.
Strong Q4 financial performance with revenue up 37.90% YoY, net income up 65.03% YoY, and EPS up 65.80% YoY.
Analysts have upgraded the stock, citing an inflection point in the advisory business and a growing M&A pipeline.
The company is expected to exceed stock-based compensation grants with share repurchases in FY26.
Bearish technical indicators, including a negative MACD and bearish moving averages.
Hedge funds and insiders are neutral with no significant trading trends.
The stock has a limited potential for outsized EPS growth compared to peers exposed to larger deals, as noted by analysts.
In Q4 2025, Piper Sandler reported strong financial results: revenue increased by 37.90% YoY to $662.04 million, net income rose by 65.03% YoY to $113.97 million, and EPS grew by 65.80% YoY to $6.40. Gross margin also improved slightly to 99.86%. These results highlight robust growth and operational efficiency.
Analysts have mixed views but lean positive overall. Northland upgraded the stock to Outperform with a $350 price target, citing a growing M&A pipeline and recent share pullback. Wolfe Research raised its price target to $398, maintaining an Outperform rating. However, BofA maintains an Underperform rating with a $395 price target, citing limited EPS growth potential compared to peers.
